In 2009 brand name drug prices rose 8 percent, even though the general inflation rate remained negative that year.
Out of 217 brand name prescription medications examined by the AARP, only 6 did not go up in price more than the inflation rate. All of the 25 top selling brand name medications went up in price, most by over 5 percent.
According to Medical News Today:
“Flomax ... a prostate drug, went up by a whopping 24.8 percent during 2009 ... Flomax rose in price 92 percent during the five years leading up to the end of its patent life. The retail price for a one-year supply of ... rose by $827 between the end of 2004 and the end of 2009.”